Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
NCT ID: NCT06629987
Last Updated: 2024-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
360 participants
OBSERVATIONAL
2021-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of a National Cohort of Adult Patients With Phenylketonuria
NCT01619722
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288
A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France
NCT06875089
A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria
NCT06628128
Testing of Four Home Phenylalanine Monitoring Prototype Devices
NCT02445521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Hospices Civils de Lyon
OTHER
University Hospital, Strasbourg, France
OTHER
CHU de Reims
OTHER
Centre Hospitalier Universitaire, Amiens
OTHER
Centre Hospitalier Universitaire Dijon
OTHER
Nantes University Hospital
OTHER
University Hospital, Tours
OTHER
Clinical Research Center of Reunion island
UNKNOWN
University Hospital, Caen
OTHER
Rennes University Hospital
OTHER
University Hospital, Bordeaux
OTHER
University Hospital, Toulouse
OTHER
University Hospital, Montpellier
OTHER
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HESS Valentin
MD, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU NANCY hopital enfant
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022PI186
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.